|
|
Volumn 11, Issue 1, 2006, Pages 77-83
|
|
Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: A single-center experience
|
|
Author keywords
Anti CD20 monoclonal antibody; Heart transplant; Post transplantation lymphoproliferative disorder; Renal transplant; Rituximab
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTIVIRUS AGENT;
AZATHIOPRINE;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
CYTARABINE;
DOXORUBICIN;
GANCICLOVIR;
IFOSFAMIDE;
IMMUNOGLOBULIN;
IMMUNOSUPPRESSIVE AGENT;
INTERFERON;
MESNA;
METHOTREXATE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
PREDNISONE;
RITUXIMAB;
THYMOCYTE ANTIBODY;
TSUKUBAENOLIDE;
VINCRISTINE;
VIRUS VACCINE;
ADULT;
AGED;
CAUCASIAN;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTION;
DIABETIC NEPHROPATHY;
DISEASE COURSE;
DRUG EFFICACY;
FATALITY;
FEMALE;
GLOMERULONEPHRITIS;
HEART TRANSPLANTATION;
HEPATITIS C;
HUMAN;
IMMUNIZATION;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
ISCHEMIC HEART DISEASE;
KIDNEY POLYCYSTIC DISEASE;
KIDNEY TRANSPLANTATION;
LYMPHOPROLIFERATIVE DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
POSTOPERATIVE COMPLICATION;
PREOPERATIVE PERIOD;
PRIMARY INFECTION;
PRIORITY JOURNAL;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
RECIPIENT;
REVIEW;
RISK FACTOR;
TREATMENT INDICATION;
TREATMENT OUTCOME;
ADULT;
AGED;
CONTINENTAL POPULATION GROUPS;
CYTOMEGALOVIRUS INFECTIONS;
EPSTEIN-BARR VIRUS INFECTIONS;
FEMALE;
HEART TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INCIDENCE;
KIDNEY TRANSPLANTATION;
LYMPHOPROLIFERATIVE DISORDERS;
MALE;
MIDDLE AGED;
PROGNOSIS;
RETROSPECTIVE STUDIES;
SEX FACTORS;
TREATMENT OUTCOME;
|
|
EID: 33645702899
PISSN: 10742484
EISSN: None
Source Type: Journal
DOI: 10.1177/107424840601100107 Document Type: Review |
|
Times cited : (49)
|
|
References (8)
|
